The Axiom Human Genotyping SARS-CoV-2 Research Array is a comprehensive whole-genome genotyping tool designed for epidemiological research of host genetics in relation to SARS-CoV-2 infectious disease. The array offers >820,000 markers prioritized for dense coverage of genes implicated in underlying conditions that may influence disease susceptibility, severity, and outcome, including coronary artery disease, chronic obstructive pulmonary disease, diabetes, and high blood pressure. The array also offers dense coverage of the ACE2 and TMPRSS2 genes associated with viral entry points, as well as coverage of relevant pharmacogenes.

The Axiom Human Genotyping SARS-CoV-2 Research Array, along with the Axiom Genotyping Solution, delivers an impactful research solution that converts samples to whole-genome data for multi-ethnic populations. The array can be used to perform both prospective studies and retrospective studies with previously generated data.